Methylphenidate hydrochloride
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedAbout Methylphenidate hydrochloride
Methylphenidate hydrochloride is a phase 3 stage product being developed by Novartis for ADHD. The current trial status is completed. This product is registered under clinical trial identifier NCT00254878. Target conditions include ADHD.
What happened to similar drugs?
10 of 20 similar drugs in ADHD were approved
Approved (10) Terminated (3) Active (9)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00254878 | Phase 3 | Completed |
Competing Products
20 competing products in ADHD